Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer

Trastuzumab-induced cardiotoxicity (TIC) is the primary adverse event that limits the use of trastuzumab in HER2-positive breast cancer patients. However, the incidence and risk factors of TIC in HER2-positive gastric cancer are not known. Therefore, we evaluated the incidence and predictive factors...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncotarget 2017-09, Vol.8 (37), p.61837-61845
Hauptverfasser:	Soo Park, Ji, Youn, Jong-Chan, Shim, Chi Young, Hong, Geu-Ru, Lee, Choong-Kun, Kim, Jee Hyung, Park, Hyung Soon, Heo, Su Jin, Beom, Seung Hoon, Kim, Hyo Song, Rha, Sun Young, Chung, Hyun Cheol, Kang, Seok-Min, Jung, Minkyu
Format:	Artikel
Sprache:	eng
Schlagworte:	Research Paper
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!